{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:47:21Z","timestamp":1791247641812,"version":"4.1.0"},"reference-count":26,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1495,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1756-185x.2011.01632.x","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T04:01:23Z","timestamp":1311912083000},"page":"345-352","source":"Crossref","is-referenced-by-count":35,"title":["Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression"],"prefix":"10.1111","volume":"14","author":[{"given":"Mohamed Hesham Mohamed","family":"EZZAT","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek Mohey Abdelmegeed","family":"EL-GAMMASY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem Yehia Ali","family":"SHAHEEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman Osman Yousef","family":"OSMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,29]]},"reference":[{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00018-007-7044-8","article-title":"Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival","volume":"64","author":"Elola","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0304-4165(02)00314-8","article-title":"Role of galectins in inflammatory and immunomodulatory processes","volume":"1572","author":"Rabinovich","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbagen.2005.11.020","article-title":"Galectin-3 in macrophage-like cells exposed to immunomodulatory drugs","volume":"1760","author":"Dabelic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/art.11287","article-title":"Galectin 3 and its binding protein in rheumatoid arthritis","volume":"48","author":"Ohshima","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/ATVBAHA.107.159160","article-title":"Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction","volume":"28","author":"Papaspyridonos","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl. 45","key":"10.1111\/j.1756-185X.2011.01632.x-BIB7|cit7","first-page":"S41","article-title":"Serum Galectin-3 and Galectin-3 binding protein levels in Beh\u00e7et\u2019s disease and their association with disease activity","volume":"25","author":"Lee","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB8|cit8","first-page":"1389","article-title":"Concentrations of Galectin-3 in the sera of normal controls and cancer patients","volume":"6","author":"Iurisci","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"21337","DOI":"10.1074\/jbc.M608810200","article-title":"Phosphorylated Galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells","volume":"282","author":"Mazurek","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.190.3.385","article-title":"Recombinant Galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis","volume":"190","author":"Rabinovich","year":"1999","journal-title":"J Exp Med"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB11|cit11","first-page":"2737","article-title":"Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism","volume":"28","author":"Berntson","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB12|cit12","first-page":"2031","article-title":"Methotrexate: vital new information about a middle aged drug","volume":"29","author":"Giannini","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.7326\/0003-4819-117-10-801","article-title":"The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis","volume":"17","author":"Weyand","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/rheumatology\/37.2.165","article-title":"HLA-DRB1 alleles associated with rheumatoid arthritis in northern Italy: correlation with disease severity","volume":"37","author":"Salvarani","year":"1998","journal-title":"Br J Rheum"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB15|cit15","first-page":"1974","article-title":"How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long term studies","volume":"22","author":"Larsen","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB16|cit16","first-page":"1976","article-title":"A modified version of Larsen\u2019s scoring method to assess radiological changes in rheumatoid arthritis","volume":"22","author":"Rau","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780310107","article-title":"Radiographic and joint count findings of the hand in rheumatoid arthritis: related and unrelated findings","volume":"31","author":"Fuchs","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T","article-title":"Sulfasalazine in treatment of juvenile rheumatoid arthritis","volume":"41","author":"Van Rossum","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/1529-0131(200004)43:4<852::AID-ANR16>3.0.CO;2-7","article-title":"Serum matrix metalloproteinases-3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis","volume":"43","author":"Yamanaka","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.24574","article-title":"Galectin-3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways","volume":"60","author":"Filer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB21|cit21","first-page":"1914","article-title":"Expression of Galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis","volume":"28","author":"Harjacek","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1023\/B:GLYC.0000014088.21242.e0","article-title":"Galectins as inflammatory mediators","volume":"19","author":"Almkvist","year":"2004","journal-title":"Glycoconj J"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/excr.1998.4253","article-title":"Galectin-3 stimulates cell proliferation","volume":"245","author":"Inohara","year":"1998","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/ard.2004.023135","article-title":"Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein","volume":"64","author":"Neidhart","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/keg257","article-title":"Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients","volume":"42","author":"Vittecoq","year":"2003","journal-title":"Rheumatology"},{"key":"10.1111\/j.1756-185X.2011.01632.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/ard.62.7.597","article-title":"Interpreting radiographic data in rheumatoid arthritis","volume":"62","author":"Ory","year":"2003","journal-title":"Ann Rheum Dis"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2011.01632.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1756-185X.2011.01632.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T22:49:22Z","timestamp":1612478962000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1756-185X.2011.01632.x"}},"subtitle":["Galectin-3: a potential marker of JIA severity"],"short-title":[],"issued":{"date-parts":[[2011,7,29]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2011.01632.x","relation":{},"ISSN":["1756-1841"],"issn-type":[{"value":"1756-1841","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,29]]}}}